Drug Type Recombinant polypeptide |
Synonyms- |
Target |
Mechanism MBL inhibitors(Mannose-binding protein C inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Phase 1 | DK | 30 Nov 2022 | |
Multiple Myeloma | Phase 1 | DK | 30 Nov 2022 | |
Neonatal infections | Phase 1 | DK | 30 Nov 2022 | |
Sepsis | Phase 1 | DK | 30 Nov 2022 |